Tramadol and Gastritis haemorrhagic - a phase IV clinical study of FDA data
Gastritis haemorrhagic is found among people who take Tramadol, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Tramadol and have Gastritis haemorrhagic. It is created by eHealthMe based on reports of 194,214 people who have side effects when taking Tramadol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
194,214 people reported to have side effects when taking Tramadol.
Among them, 33 people (0.02%) have Gastritis haemorrhagic.
What is Tramadol?
Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 200,042 Tramadol users for its effectiveness, alternative drugs and more.
What is Gastritis haemorrhagic?
Gastritis haemorrhagic (inflammation of stomach with bleeding) is found to be associated with 703 drugs and 375 conditions by eHealthMe.
Number of Tramadol and Gastritis haemorrhagic reports submitted per year:
Time on Tramadol when people have Gastritis haemorrhagic *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Gastritis haemorrhagic when taking Tramadol *:
- female: 78.12 %
- male: 21.88 %
Age of people who have Gastritis haemorrhagic when taking Tramadol *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 7.14 %
- 40-49: 0.0 %
- 50-59: 7.14 %
- 60+: 85.71 %
Common drugs people take besides Tramadol *:
- Lithium Carbonate: 9 people, 27.27%
- Inderal: 7 people, 21.21%
- Furosemide: 7 people, 21.21%
- Diclofenac: 7 people, 21.21%
- Clorazepate Dipotassium: 7 people, 21.21%
- Vioxx: 6 people, 18.18%
- Ponstel: 6 people, 18.18%
- Xarelto: 5 people, 15.15%
- Amlodipine: 5 people, 15.15%
- Luvox: 5 people, 15.15%
Common side effects people have besides Gastritis haemorrhagic *:
- Thrombocytopenia (decrease of platelets in blood): 11 people, 33.33%
- Hypotension (abnormally low blood pressure): 10 people, 30.30%
- Anaemia (lack of blood): 10 people, 30.30%
- Renal Failure Acute (rapid kidney dysfunction): 9 people, 27.27%
- Gastric Ulcer (stomach ulcer): 9 people, 27.27%
- Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 9 people, 27.27%
- Consciousness - Decreased: 9 people, 27.27%
- Bradycardia (abnormally slow heart action): 8 people, 24.24%
- Suicide Attempt: 8 people, 24.24%
- Oedema Peripheral (superficial swelling): 8 people, 24.24%
Common conditions people have *:
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 27.27%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 21.21%
- Ill-Defined Disorder: 5 people, 15.15%
- Chest Pain: 5 people, 15.15%
- Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 4 people, 12.12%
- Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 4 people, 12.12%
- Bipolar Disorder (mood disorder): 4 people, 12.12%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.03%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 3.03%
- Nausea (feeling of having an urge to vomit): 1 person, 3.03%
* Approximation only. Some reports may have incomplete information.
Do you take Tramadol and have Gastritis haemorrhagic?Check whether Gastritis haemorrhagic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How severe was Gastritis haemorrhagic and when was it recovered:
Expand to all the drugs that have ingredients of tramadol hydrochloride:
Alternative drugs to, pros and cons of Tramadol:
- Tramadol (200,042 reports)
Common Tramadol side effects:
Browse all side effects of Tramadol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Gastritis haemorrhagic treatments and more:
- Gastritis haemorrhagic (2,182 reports)
COVID vaccines that are related to Gastritis haemorrhagic:
- Gastritis haemorrhagic in Moderna COVID Vaccine
- Gastritis haemorrhagic in Pfizer BioNTech Covid Vaccine
- Gastritis haemorrhagic in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastritis haemorrhagic:
All the drugs that are associated with Gastritis haemorrhagic:
- Gastritis haemorrhagic (703 drugs)
Common conditions associated with Gastritis haemorrhagic:
- Atrial fibrillation: 363 reports
- Atrial fibrillation/flutter: 363 reports
- Auricular fibrillation: 358 reports
- Hbp: 159 reports
- High blood pressure: 159 reports
- Stroke: 320 reports
All the conditions that are associated with Gastritis haemorrhagic:
- Gastritis haemorrhagic (375 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Januvia and Bone Cyst - now
- Rheumatoid Arthritis and Blood Immunoglobulin G Decreased - 10 seconds ago
- Thalomid and Paroxysmal Supraventricular Tachycardia - 12 seconds ago
- Guaifenesin and Tolerance Increased - 22 seconds ago
- Inderal La and Salagen drug interaction - 23 seconds ago
- Cefuroxime Axetil and Blopress drug interaction - 25 seconds ago
- Dyazide vs. Esidrix - 27 seconds ago
- Gaba and Pre-Existing Condition Improved - 30 seconds ago
- Type 2 Diabetes and Renal Function Test Abnormal - 49 seconds ago
- Lovastatin and Impaired Gastric Emptying - a minute ago